The Amarin Win: How Cahill Gordon Took On The FDA

Name: Cahill
Price range: $$$

March 18, 2016

Floyd Abrams and Joel Kurtzberg discuss their landmark First Amendment victory on behalf of Amarin Pharma against the FDA that enables Amarin to truthfully and non-misleadingly promote to doctors and other healthcare professionals an off-label use of its omega-3 drug Vascepa.

Read the Law 360 article The Amarin Win: How Cahill Gordon Took On The FDA (subscription required)